Medicaid coverage
North Carolina: what Medicaid covers
North Carolina stopped covering GLP-1s for obesity on October 1, 2025 and reinstated coverage on December 12, 2025, back to the criteria that applied on September 30, 2025.
| Drug | Position | Criteria |
|---|---|---|
| Semaglutide | Prior authorization | Wegovy is the preferred product Changed December 12, 2025 |
| Tirzepatide | Prior authorization | Non-preferred. Requires a trial and failure of Wegovy first Changed December 12, 2025 |
| Liraglutide | Prior authorization | Non-preferred. Requires a trial and failure of Wegovy first Changed December 12, 2025 |
-
Semaglutide Prior authorization
Wegovy is the preferred product
Changed December 12, 2025
-
Tirzepatide Prior authorization
Non-preferred. Requires a trial and failure of Wegovy first
Changed December 12, 2025
-
Liraglutide Prior authorization
Non-preferred. Requires a trial and failure of Wegovy first
Changed December 12, 2025
Sources
Every claim above is checked against the primary text, and the date is the day we last opened it.
-
1
NC Medicaid to Reinstitute Coverage of GLP-1s for Weight Management
North Carolina Department of Health and Human Services, Division of Health Benefits Primary text read and checked Checked August 25, 2026